How big is the Inflammatory Bowel Disease Therapeutics Market?

The Inflammatory Bowel Disease Therapeutics Market size is expected to reach USD 24.46 billion in 2024 and grow at a CAGR of 5.15% to reach USD 31.43 billion by 2029. Read More

What is the current Inflammatory Bowel Disease Therapeutics Market size?

In 2024, the Inflammatory Bowel Disease Therapeutics Market size is expected to reach USD 24.46 billion. Read More

Who are the key players in Inflammatory Bowel Disease Therapeutics Market?

Bristol-Myers Squibb Company, AbbVie Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc. (Janssen Biotech, Inc.) and Bausch Health Companies Inc. (Salix Pharmaceuticals) are the major companies operating in the Inflammatory Bowel Disease Therapeutics Market. Read More

Which is the fastest growing region in Inflammatory Bowel Disease Therapeutics Market?

Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Inflammatory Bowel Disease Therapeutics Market?

In 2024, the North America accounts for the largest market share in Inflammatory Bowel Disease Therapeutics Market. Read More

What years does this Inflammatory Bowel Disease Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Inflammatory Bowel Disease Therapeutics Market size was estimated at USD 23.20 billion. The report covers the Inflammatory Bowel Disease Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Inflammatory Bowel Disease Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Inflammatory Bowel Disease (IBD) Therapeutics Companies

This report lists the top Inflammatory Bowel Disease (IBD) Therapeutics companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Inflammatory Bowel Disease (IBD) Therapeutics industry.